Abstract
To investigate the effects of clarithromycin (0.01-0.5 mg/L) alone or in combination with ceftriaxone (0.1 and 0.25 mg/L) on pneumolysin production by both macrolide-susceptible and -resistant [2 erm(B) positive and 2 mef(A) positive] strains of Streptococcus pneumoniae.
| Original language | English |
|---|---|
| Pages (from-to) | 224-9 |
| Number of pages | 6 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 59 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2007 |
Keywords
- Anti-Bacterial Agents
- Bacterial Proteins
- Ceftriaxone
- Clarithromycin
- Dose-Response Relationship, Drug
- Drug Resistance, Bacterial
- Drug Synergism
- Microbial Sensitivity Tests
- Polymerase Chain Reaction
- Streptococcus pneumoniae
- Streptolysins
Fingerprint
Dive into the research topics of 'Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver